ImmunityBio, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of IBRX for the last quarter is 1.05 M USD, and it's 2517.50% higher compared to the previous quarter. The net income of Q2 24 is -134.56 M USD.